These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 19362602

  • 21. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C, Baftiu A, Tysse I, Valsø B, Larsson PG, Rytter E, Johannessen SI.
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [Abstract] [Full Text] [Related]

  • 22. Lamotrigine and its N2-glucuronide during pregnancy: the significance of renal clearance and estradiol.
    Reimers A, Helde G, Bråthen G, Brodtkorb E.
    Epilepsy Res; 2011 May; 94(3):198-205. PubMed ID: 21356585
    [Abstract] [Full Text] [Related]

  • 23. Serial Monitoring of Plasma Levetiracetam Levels in a Child With Epilepsy Undergoing Cord Blood Transplantation.
    Motobayashi M, Morita D, Kurata T, Shigemura T, Nakazawa Y, Shimozawa N, Inaba Y.
    Pediatr Neurol; 2016 Nov; 64():e5-e6. PubMed ID: 27546598
    [No Abstract] [Full Text] [Related]

  • 24. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
    Lancelin F, Franchon E, Kraoul L, Garciau I, Brovedani S, Tabaouti K, Landré E, Chassoux F, Paubel P, Piketty ML.
    Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic drug monitoring in pregnancy: Levetiracetam.
    Fallik N, Trakhtenbroit I, Fahoum F, Goldstein L.
    Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747
    [Abstract] [Full Text] [Related]

  • 26. Levetiracetam pharmacokinetics in neonates at birth.
    Allegaert K, Lewi L, Naulaers G, Lagae L.
    Epilepsia; 2006 Jun; 47(6):1068-9. PubMed ID: 16822254
    [Abstract] [Full Text] [Related]

  • 27. Therapeutic Drug Monitoring of Levetiracetam in Different Trimesters of Pregnant Women with Epilepsy in a Tertiary Care Center: A Prospective Study.
    Kumaravel J, Sarma P, Suri V, Singh P, Prakash A, Medhi B.
    Neurol India; 2024 Mar 01; 72(2):358-363. PubMed ID: 38691482
    [Abstract] [Full Text] [Related]

  • 28. Clinically relevant reduction of lamotrigine concentrations by carbamazepine.
    Koch HJ, Szecsey A, Vogel M.
    Eur Psychiatry; 2003 Feb 01; 18(1):42. PubMed ID: 12648898
    [No Abstract] [Full Text] [Related]

  • 29. Contraception, pregnancy and lactation in women with epilepsy.
    Yerby MS.
    Baillieres Clin Neurol; 1996 Dec 01; 5(4):887-908. PubMed ID: 9068887
    [Abstract] [Full Text] [Related]

  • 30. Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy.
    Freitas-Lima P, Alexandre V, Pereira LR, Feletti F, Perucca E, Sakamoto AC.
    Epilepsy Res; 2011 Mar 01; 94(1-2):117-20. PubMed ID: 21282041
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic Drug Monitoring of Levetiracetam and Lamotrigine: Is There a Need?
    Naik GS, Kodagali R, Mathew BS, Thomas M, Prabha R, Mathew V, Fleming DH.
    Ther Drug Monit; 2015 Aug 01; 37(4):437-44. PubMed ID: 25478905
    [Abstract] [Full Text] [Related]

  • 32. Carbamazepine in pregnancy: Levetiracetam and lamotrigine are better options.
    Iniesta I.
    BMJ; 2011 Jan 25; 342():d279. PubMed ID: 21266422
    [No Abstract] [Full Text] [Related]

  • 33. Levetiracetam use during pregnancy in women with epilepsy: Preliminary observations from a tertiary care center in Northern India.
    Bansal R, Suri V, Chopra S, Aggarwal N, Sikka P, Saha SC, Goyal MK, Kumar P.
    Indian J Pharmacol; 2018 Jan 25; 50(1):39-43. PubMed ID: 29861526
    [Abstract] [Full Text] [Related]

  • 34. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
    Gidal BE, Baltès E, Otoul C, Perucca E.
    Epilepsy Res; 2005 Jan 25; 64(1-2):1-11. PubMed ID: 15823510
    [Abstract] [Full Text] [Related]

  • 35. Monitoring levetiracetam concentration in saliva during pregnancy is stable and feasible.
    Li W, Yang X, Chen Q, Wang Z, Duan Y, Chen L.
    CNS Neurosci Ther; 2024 Jul 25; 30(7):e14827. PubMed ID: 38992878
    [Abstract] [Full Text] [Related]

  • 36. Lamotrigine use in pregnancy.
    Moore JL, Aggarwal P.
    Expert Opin Pharmacother; 2012 Jun 25; 13(8):1213-6. PubMed ID: 22594849
    [Abstract] [Full Text] [Related]

  • 37. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
    Tan J, Paquette V, Levine M, Ensom MHH.
    Clin Pharmacokinet; 2017 Nov 25; 56(11):1267-1285. PubMed ID: 28353057
    [Abstract] [Full Text] [Related]

  • 38. Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.
    Mazzucchelli I, Onat FY, Ozkara C, Atakli D, Specchio LM, Neve AL, Gatti G, Perucca E.
    Epilepsia; 2006 Mar 25; 47(3):504-9. PubMed ID: 16529613
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S, Cao J, Xiao N, Cai F.
    J Child Neurol; 2010 May 25; 25(5):609-13. PubMed ID: 19779208
    [Abstract] [Full Text] [Related]

  • 40. Lamotrigine clearance during pregnancy.
    Tran TA, Leppik IE, Blesi K, Sathanandan ST, Remmel R.
    Neurology; 2002 Jul 23; 59(2):251-5. PubMed ID: 12136066
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.